Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.

Butyrophilin 3A1 (BTN3A1) binds small phosphorus-containing molecules, which initiates transmembrane signaling and activates butyrophilin-responsive cells. We synthesized several phosphinophosphonates and their corresponding tris-pivaloyloxymethyl (tris-POM) prodrugs and examined their effects on BTN3A1. An analog of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) bound to BTN3A1 with intermediate affinity, which was enthalpy-driven. Docking studies revealed binding to the basic surface pocket and interactions between the allylic hydroxyl group and the BTN3A1 backbone. The phosphinophosphonate stimulated proliferation of Vγ9Vδ2 T cells with moderate activity (EC50 = 26 μM). Cellular potency was enhanced >600-fold in the tris-POM prodrug (EC50 = 0.041 μM). The novel prodrug also induced T cell mediated leukemia cell lysis. Analysis of dose-response data reveals HMBPP-induced Hill coefficients of 0.69 for target cell lysis and 0.68 in interferon secretion. Together, tris-POM prodrugs enhance the cellular activity of phosphinophosphonates, reveal structure-activity relationships of butyrophilin ligands, and support a negatively cooperative model of cellular butyrophilin activation.

[1]  B. Yan,et al.  Covalent inhibition of carboxylesterase-2 by sofosbuvir and its effect on the hydrolytic activation of tenofovir disoproxil. , 2017, Journal of hepatology.

[2]  A. Wiemer,et al.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier. , 2016, Topics in current chemistry.

[3]  A. Wiemer,et al.  HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors , 2016, The Journal of Immunology.

[4]  E. Adams,et al.  RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor. , 2016, Cell reports.

[5]  J. Trowsdale,et al.  Regulation of Immunity by Butyrophilins. , 2016, Annual review of immunology.

[6]  Hong Wang,et al.  Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells , 2015, The Journal of Immunology.

[7]  P. Sharma,et al.  Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential , 2015, Cell.

[8]  D. Fearon,et al.  T cell exclusion, immune privilege, and the tumor microenvironment , 2015, Science.

[9]  J. Trowsdale,et al.  Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin , 2015, The Journal of Immunology.

[10]  H. Shmeeda,et al.  Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid , 2014, The Journal of Immunology.

[11]  O. Vinogradova,et al.  Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes. , 2014, Chemistry & biology.

[12]  A. Wiemer,et al.  Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists. , 2014, Biochemical pharmacology.

[13]  G. Kéri,et al.  Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors. , 2014, Journal of medicinal chemistry.

[14]  E. Born,et al.  Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase. , 2014, Bioorganic & medicinal chemistry.

[15]  James E. Crooks,et al.  The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. , 2014, Immunity.

[16]  M. Distefano,et al.  Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells , 2013, The Journal of Immunology.

[17]  N. K. Williams,et al.  Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells , 2013, Nature Immunology.

[18]  V. Herring,et al.  The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? , 2013, Pharmacotherapy.

[19]  E. Adams,et al.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. , 2012, Blood.

[20]  Marc Bonneville,et al.  The Molecular Basis for Modulation of Human Vγ9Vδ2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies* , 2012, The Journal of Biological Chemistry.

[21]  M. Eberl,et al.  Human γδ T‐cell responses in infection and immunotherapy: Common mechanisms, common mediators? , 2012, European journal of immunology.

[22]  A. Wiemer,et al.  Isoprenoid metabolism as a therapeutic target in gram-negative pathogens. , 2010, Current topics in medicinal chemistry.

[23]  Christian Belmant,et al.  Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate. , 2008, Journal of medicinal chemistry.

[24]  H. Jomaa,et al.  Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human γδ T cells but does not lead to competitive antagonism , 2003 .

[25]  E. Oldfield,et al.  Quantitative structure-activity relations for γδ T cell activation by phosphoantigens , 2002 .

[26]  E. De Clercq,et al.  Antiretroviral Efficacy and Pharmacokinetics of Oral Bis(isopropyloxycarbonyloxymethyl)9-(2-Phosphonylmethoxypropyl)adenine in Mice , 1998, Antimicrobial Agents and Chemotherapy.

[27]  J. Allison,et al.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.

[28]  R. Schwartz.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.

[29]  C. Poulter,et al.  Novel phosphonylphosphinyl (P-C-P-C-) analogues of biochemically interesting diphosphates. Syntheses and properties of P-C-P-C- analogues of isopentenyl diphosphate and dimethylallyl diphosphate [17] , 1987 .

[30]  C. McKenna,et al.  The facile dealkylation of phosphonic acid dialkyl esters by bromotrimethylsilane , 1977 .

[31]  D. Koshland,et al.  Negative cooperativity in enzyme action. The binding of diphosphopyridine nucleotide to glyceraldehyde 3-phosphate dehydrogenase. , 1968, Biochemistry.

[32]  M. L. Geng,et al.  Evaluation of a 7‐Methoxycoumarin‐3‐carboxylic Acid Ester Derivative as a Fluorescent, Cell‐Cleavable, Phosphonate Protecting Group , 2016, Chembiochem : a European journal of chemical biology.

[33]  James E. Crooks,et al.  The Intracellular B 30 . 2 Domain of Butyrophilin 3 A 1 Binds Phosphoantigens to Mediate Activation of Human V g 9 V d 2 T Cells , 2014 .

[34]  A. Hayday,et al.  Butyrophilins: an emerging family of immune regulators. , 2012, Trends in immunology.

[35]  H. Jomaa,et al.  Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism. , 2003, Bioorganic & medicinal chemistry letters.

[36]  E. Oldfield,et al.  Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens. , 2002, Journal of medicinal chemistry.

[37]  A. Hill,et al.  The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves , 1910 .